Evidence map›Paper›PMID 20851882›Full record

ArticleThe Journal of biological chemistry2010

The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Naga Suresh Adapala, Mary F Barbe, Wallace Y Langdon, Mary C Nakamura, Alexander Y Tsygankov, Archana Sanjay

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Naga Suresh AdapalaDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Mary F Barbe
Wallace Y Langdon
Mary C Nakamura
Alexander Y Tsygankov
Archana Sanjay
Temple University · USSan Francisco VA Medical Center · USUniversity of Western Australia · AU

Funding

Regulation of Osteoclast Function : Role of the Cbl-PI3K ComplexR01AR055601 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SANJAY, ARCHANA · 2008 to 2012
$1.6M
High-resolution ex vivo micro-computerized tomography systemS10RR026727 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · PI BARBE, MARY F · 2010 to 2010
$308k
NCRR NIH HHS S10 RR026727NIAMS NIH HHS AR055601NIAMS NIH HHS R01 AR055601
6 · The paper itself

Abstract

Cbl is an adaptor protein and an E3 ligase that plays both positive and negative roles in several signaling pathways that affect various cellular functions. Tyrosine 737 is unique to Cbl and is phosphorylated by Syk and Src family kinases. Phosphorylated Cbl Tyr(737) creates a binding site for the p85 regulatory subunit of PI3K, which also plays an important role in the regulation of bone resorption by osteoclasts. To investigate the role of Cbl-PI3K interaction in bone homeostasis, we examined the knock-in mice (Cbl(YF/YF)) in which the PI3K binding site in Cbl is ablated due to the mutation in the regulatory tyrosine. We report that in Cbl(YF/YF) mice, despite increased numbers of osteoclasts, bone volume is increased due to defective osteoclast function. Additionally, in ex vivo cultures, mature Cbl(YF/YF) osteoclasts showed an increased ability to survive in the presence of RANKL due to delayed onset of apoptosis. RANKL-mediated signaling is perturbed in Cbl(YF/YF) osteoclasts, and most interestingly, AKT phosphorylation is up-regulated, suggesting that the lack of PI3K sequestration by Cbl results in increased survival and decreased bone resorption. Cumulatively, these in vivo and in vitro results show that, on one hand, binding of Cbl to PI3K negatively regulates osteoclast differentiation, survival, and signaling events (e.g. AKT phosphorylation), whereas on the other hand it positively influences osteoclast function.

Indexed as

ApoptosisAnimalsBlotting, WesternBone ResorptionCell DifferentiationCell ProliferationCells, CulturedFlow CytometryFluorescent Antibody TechniqueImmunoenzyme TechniquesMiceMice, Inbred C57BLMice, KnockoutOsteoclastsPhosphatidylinositol 3-KinasePhosphorylationCbl protein, mousePhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-cblRANK LigandRNA, Messenger

Identifiers

PMID20851882
PMCPMC2978603
OpenAlexW2025782870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.